SEARCH BLOG


Allergan Patent Controversy Continues

Seeking protection from the patent challenges brought by generic drug makers, Allergan Plc made an unusual, and controversial, deal back in September.
Seeking protection from the patent challenges brought by generic drug makers, Allergan Plc made an unusual, and controversial, deal back in September that has continued to make wa… https://www.globalpatentsolutions.com/blog/2017/12/allergan-patent-controversy-continues/

WIPO & Pharma Team-Up with Pat-INFORMED Program

The Patent Information Initiative for Medicines (Pat-INFORMED) aims to create a common platform or database of key medicine patents & information, accessible to health professionals worldwide. 
Earlier this month, the World Intellectual Property Organization (WIPO), in partnership with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), s… https://www.globalpatentsolutions.com/blog/2017/10/wipo-pharma-team-pat-informed-program/

Allergan Strikes Unconventional Deal to Protect Patents

Allergan, Plc has struck a deal with the Saint Regis Mohawk Tribe that will protect its patents.
Allergan, Plc has struck a deal with the Saint Regis Mohawk Tribe that will protect its patents on the popular eye medication, Restasis.  “The Tribe, a recognized sovereign tribal… https://www.globalpatentsolutions.com/blog/2017/09/allergan-strikes-unconventional-deal-protect-patents/

FluMist Flop: CDC Finds Inventive Vaccine Ineffective

The CDC has recently withdrawn its recommendation for the FluMist, leaving thousands of children and adults with only one option: the shot. 
Flu season is just around the corner, and the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics have withdrawn their recommendations for the FluM… https://www.globalpatentsolutions.com/blog/2016/09/flumist-flop-cdc-findsinventive-vaccine-ineffective/

Mylan Pharmaceuticals Under Fire for EpiPen Price Jump

Mylan Pharmaceuticals is catching a lot of heat after raising the price of its EpiPen by over 400%.
Mylan Pharmaceuticals is catching a lot of heat after raising the price of its EpiPen by over 400% in the last few years.  Since acquiring the injectable allergy medicine in 2007,… https://www.globalpatentsolutions.com/blog/2016/08/mylan-pharmaceuticals-under-fire-epipen-price-jump/

Pharma Patents & The Battle of Brand V. Generic

The U.S. has seen a significant shift from brand-name prescription drugs to generics.
With a number of big brand-name drugs slated to lose patents this year, generic manufacturers are eager to push their products to market... And consumers are just as eager to get … https://www.globalpatentsolutions.com/blog/2016/08/pharma-patents-battle-brand-v-generic/

Friend or Foe? Companies Settle Up With Patent Rivals

According to Unified Patents' 1st Half 2016 Patent Dispute Report, the numbers for litigation are down.
According to Unified Patents' 1st Half 2016 Patent Dispute Report, the numbers for litigation are down.  Records show that the number of patent cases has decreased in the last hal… https://www.globalpatentsolutions.com/blog/2016/07/friend-or-foe-companies-settle-patent-rivals/

GSK Announces New "Graduated" Approach to Patents

GlaxoSmithKline recently made the shocking announcement that it will no longer seek patents for pharmaceuticals in developing and other low-income countries.
GlaxoSmithKline recently made the shocking announcement that it will no longer seek patents for pharmaceuticals in developing and other low-income countries.  In a recent press r… https://www.globalpatentsolutions.com/blog/2016/04/gsk-announces-new-graduated-approach-patents/

Pfizer Settles Seven Year Lawsuit with $784 Million

Just recently, Pfizer announced that its Wyeth unit will pay nearly $785 million to settle a long-standing lawsuit regarding its heartburn drug, Protonix.
  Just recently, Pfizer announced that its Wyeth unit will pay nearly $785 million to settle a long-standing lawsuit regarding its heartburn drug, Protonix.   Wyeth first came … https://www.globalpatentsolutions.com/blog/2016/03/pfizer-settles-seven-year-lawsuit-784-million/

UK Continues to Fight Dementia with Research and Innovation

UK continues to battle dementia with innovative global developments.
In 2014, at an industry conference in London, UK Prime Minister David Cameron announced a new agenda aimed at fighting "one of the greatest enemies of humanity," dementia.  Here, … https://www.globalpatentsolutions.com/blog/2016/01/uk-continues-fight-dementia-research-and-innovation/

WTO Extends Waiver on Patents for LDCs

The World Trade Organization recently decided to extend a waiver on patents for pharmaceutical products for Least-Developed Country members (LDC).
The WTO Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreed to an extension of the pharmaceutical IP waiver for LDCs on Friday, allowing members to av… https://www.globalpatentsolutions.com/blog/2015/11/wto-extends-waiver-patents-ldcs/

Big Pharma Pushes for Controversial Patent Reform

Big brand pharmaceutical companies are pushing for patent reform that could prove taxing on generic drug makers and consumers. 
Big brand pharmaceutical companies are pushing for patent reform that could prove taxing on generic drug makers and consumers.    Currently, the process of Inter Partes Revi… https://www.globalpatentsolutions.com/blog/2015/09/big-pharma-pushes-controversial-patent-reform/

New Cure for Hepatitis C: Patent Litigation & High Price

A new cure for hepatitis C is causing controversy with its $84,000 price and string of patent disputes.
A new cure for hepatitis C is causing controversy with its $84,000 price tag for 12 weeks of treatment.  Gilead Sciences Inc.’s new drug, Sovaldi, may cost roughly $1,000 per pill… https://www.globalpatentsolutions.com/blog/2014/07/new-cure-hepatitis-c-patent-litigation-high-price/

Antibiotic Resistance, Patents, and A Global Health Plan

With antibiotics now available to lower-income countries, the rate at which bacteria are evolving is rapidly increasing.
As global antibiotic use continues to rise, so does the number of drug-resistant bacteria.  Studies by the Center for Disease Dynamics, Economics & Policy (CDDEP) and Princeton Un… https://www.globalpatentsolutions.com/blog/2014/07/antibiotic-resistance-patents-and-global-health-plan/

Bowman v. Monsanto Co. -- A Watershed Moment for Biotech Patents?

This is a well-covered topic, but the implications for biotech patents are so significant that it is worthy of understanding by all intellectual property professionals. Whether you are a patent attorney, a patent agent, a person performing patent search,…
By Ralph "Donnie" Turlington, Research Analyst                         On March 19, 2013 the U.S. Supreme Court decided in favor of the chemical and agricultural biotechnology … https://www.globalpatentsolutions.com/blog/2014/06/bowman-v-monsanto-co-watershed-moment-biotech-patents/

UK Prime Minister Announces Plans to Fight Dementia

At an industry conference in London yesterday, UK Prime Minister David Cameron announced the launch of a new program aimed at increasing funding for research related to dementia.
At an industry conference in London yesterday, UK Prime Minister David Cameron announced the launch of a new program aimed at increasing funding for research related to dementia. … https://www.globalpatentsolutions.com/blog/2014/06/uk-prime-minister-announces-plans-fight-dementia/

THE FATE OF EMBRYONIC STEM CELL PATENTS

This is a pretty detailed blog post. It is focused very specifically at describing the fate of embryonic stem cell patents.
THE FATE OF EMBRYONIC STEM CELL PATENTS By Alexcia Linthicum | April 23, 2014   In 1998, Dr. James A. Thomson isolated human embryonic stem (ES) cells and he assigned a … https://www.globalpatentsolutions.com/blog/2014/06/fate-embryonic-stem-cell-patents/

The Legalization of Marijuana and China's Lead in Patents

On January 1st Colorado residents lined the streets, waiting to legally buy marijuana for recreational use for the first time...
On January 1st Colorado residents lined the streets, waiting to legally buy marijuana for recreational use for the first time. As the legalization of marijuana continues to inc… https://www.globalpatentsolutions.com/blog/legalization-marijuana-and-chinas-lead-patents/

Trans-Pacific Partnership Negotiations Continue into 2014

Negotiations over the Trans-Pacific Partnership (TPP) will continue on into 2014 as the U.S., Canada, and 10 other countrie...
Negotiations over the Trans-Pacific Partnership (TPP) will continue on into 2014 as the U.S., Canada, and 10 other countries in the Asia-Pacific area work to settle on a multi-b… https://www.globalpatentsolutions.com/blog/trans-pacific-partnership-negotiations-continue-2014/

FTC Changes HSR Act for Pharmaceutical Companies

The Federal Trade Commission recently revised the rules to the HSR Act regarding when pharmaceutical companies are required t...
The Federal Trade Commission recently revised the rules to the HSR Act regarding when pharmaceutical companies are required to report a transfer of exclusive patent rights to the … https://www.globalpatentsolutions.com/blog/ftc-changes-hsr-act-pharmaceutical-companies/

« Previous 12 Next »

Latest Posts

Posts By Category


RECEIVE A SYNOPSIS OF OUR STAFF BIOGRAPHIES




DOWNLOAD WHITEPAPERS